CVLVX
Price
$14.95
Change
-$0.00 (-0.00%)
Updated
Aug 19 closing price
Net Assets
25.72M
VIVIX
Price
$70.65
Change
+$0.33 (+0.47%)
Updated
Aug 19 closing price
Net Assets
195.81B
Interact to see
Advertisement

CVLVX vs VIVIX

Header iconCVLVX vs VIVIX Comparison
Open Charts CVLVX vs VIVIXBanner chart's image
Cullen Value I
Price$14.95
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets25.72M
Vanguard Value Index I
Price$70.65
Change+$0.33 (+0.47%)
VolumeN/A
Net Assets195.81B
CVLVX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CVLVX vs. VIVIX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVLVX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. CVLVX (25.7M). VIVIX pays higher dividends than CVLVX: VIVIX (2.19) vs CVLVX (1.13). CVLVX was incepted earlier than VIVIX: CVLVX (13 years) vs VIVIX (27 years). CVLVX (2.43) is less costly to investors than VIVIX (0.04). CVLVX is a more actively managed with annual turnover of: 27.00 vs. VIVIX (9.00). CVLVX has a lower initial minimum investment than VIVIX: CVLVX (1000000) vs VIVIX (5000000). CVLVX annual gain was more profitable for investors over the last year : 9.83 vs. VIVIX (7.59). VIVIX return over 5 years is better than : 70.23 vs. CVLVX (11.65).
CVLVXVIVIXCVLVX / VIVIX
Total Expense Ratio0.750.041,875%
Annual Report Gross Expense Ratio2.430.046,075%
Fund Existence13 years27 years-
Gain YTD12.0766.548184%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets25.7M196B0%
Annual Yield % from dividends1.132.1952%
Returns for 1 year9.837.59130%
Returns for 3 years11.2327.0442%
Returns for 5 years11.6570.2317%
Returns for 10 years37.27127.4529%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB1.240.05
+4.20%
PDS Biotechnology Corp
MASI153.930.06
+0.04%
Masimo Corp
TAVIU10.54N/A
N/A
Tavia Acquisition Corp
IMCR32.31-0.57
-1.73%
Immunocore Holdings plc
TNXP40.07-11.28
-21.97%
Tonix Pharmaceuticals Holding Corp